These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3799441

  • 41. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
    Fananapazir L, Epstein SE.
    Am J Cardiol; 1991 Jan 15; 67(2):175-82. PubMed ID: 1987719
    [Abstract] [Full Text] [Related]

  • 42. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW, Finerman WB, Peter T, Mandel WJ.
    Am Heart J; 1981 Dec 15; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [Abstract] [Full Text] [Related]

  • 43. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN, Anderson KP, Winkle RA, Swerdlow CD, Mason JW.
    Circulation; 1983 Jul 15; 68(1):88-94. PubMed ID: 6851057
    [Abstract] [Full Text] [Related]

  • 44. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct 15; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 45. A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.
    Bashir Y, Paul VE, Griffith MJ, Sneddon JF, Farrell TG, Ward DE, Camm AJ.
    Am Heart J; 1992 Nov 15; 124(5):1233-40. PubMed ID: 1442491
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone.
    Aiba T, Shimizu W, Inagaki M, Satomi K, Taguchi A, Kurita T, Suyama K, Aihara N, Sunagawa K, Kamakura S.
    Pacing Clin Electrophysiol; 2004 Jul 15; 27(7):901-9. PubMed ID: 15271008
    [Abstract] [Full Text] [Related]

  • 49. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
    Kato K.
    Ann N Y Acad Sci; 1992 Jan 27; 644():235-45. PubMed ID: 1562118
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
    Naccarelli GV, Fineberg NS, Zipes DP, Heger JJ, Duncan G, Prystowsky EN.
    J Am Coll Cardiol; 1985 Oct 27; 6(4):814-21. PubMed ID: 3928727
    [Abstract] [Full Text] [Related]

  • 52. [Efficacy of the combination of low doses of beta-blockers and amiodarone in the treatment of refractory ventricular tachycardia].
    Tonet J, Frank R, Fontaine G, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1989 Sep 27; 82(9):1511-7. PubMed ID: 2573326
    [Abstract] [Full Text] [Related]

  • 53. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M, Peter T, Weiss D, Nalos PC, Gang ES, Oseran DS, Mandel WJ.
    Am Heart J; 1990 Jan 27; 119(1):8-14. PubMed ID: 2296879
    [Abstract] [Full Text] [Related]

  • 54. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
    Russo AM, Beauregard LM, Waxman HL.
    Am J Cardiol; 1993 Dec 15; 72(18):1395-9. PubMed ID: 8256733
    [Abstract] [Full Text] [Related]

  • 55. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI, Anderson JL, Nanas JN, Lutz JR, Smith RA, Anderson KP, Crapo RO, Call NB.
    Can J Cardiol; 1986 Dec 15; 2(3):138-45. PubMed ID: 2941121
    [Abstract] [Full Text] [Related]

  • 56. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M, Milei J, Piñeiro DJ, Buceta JE, Dreyer MP.
    Acta Cardiol; 1983 Dec 15; 38(2):125-32. PubMed ID: 6603085
    [Abstract] [Full Text] [Related]

  • 57. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction.
    Rodriguez LM, Smeets J, O'Hara GE, Geelen P, Brugada P, Wellens HJ.
    Am J Cardiol; 1992 Jun 01; 69(17):1403-6. PubMed ID: 1590227
    [Abstract] [Full Text] [Related]

  • 58. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A, Di Pede F, Delise P, Piccolo E.
    G Ital Cardiol; 1984 Sep 01; 14(9):644-54. PubMed ID: 6510619
    [Abstract] [Full Text] [Related]

  • 59. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep 01; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.